Abstract
This comparison of PRAsugrel and clopidogrel in Japanese patients with ischemic STROke (PRASTRO)-I trial investigates the noninferiority of prasugrel to clopidogrel sulfate in the prevention of recurrence of primary events (ischemic stroke, myocardial infarction, and death from other vascular causes), and the long-term safety of prasugrel in Japanese patients with non-cardioembolic stroke. This was an active-controlled, randomized, double-blind, double-dummy, parallel-group study conducted between July 2011 and March 2016 at multiple centers around Japan. Patients had to meet eligibility criteria before receiving 3.75 mg prasugrel or 75 mg clopidogrel orally once daily for a period of 96-104 weeks. A total of 3747 patients were included in this trial; 1598 in the 3.75 mg prasugrel group and 1551 in the 75 mg clopidogrel group completed the study. During the study period, 287 (15.2%) patients in the prasugrel group and 311 (16.7%) in the clopidogrel group discontinued treatment. Baseline characteristics, safety, and efficacy results are forthcoming and will be published separately. This article presents the study design and rationale for a trial investigating the noninferiority of prasugrel to clopidogrel sulfate with regards to...Continue Reading
References
Oct 1, 1985·Clinical Pharmacology and Therapeutics·K NakamuraR A Branch
Jan 1, 1993·Stroke; a Journal of Cerebral Circulation·H P AdamsE E Marsh
Jun 1, 1994·Stroke; a Journal of Cerebral Circulation
Jan 8, 1994·BMJ : British Medical Journal
Jan 12, 2002·BMJ : British Medical Journal·UNKNOWN Antithrombotic Trialists' Collaboration
Jul 28, 2005·Diabetes·Dominick J AngiolilloCarlos Macaya
Sep 29, 2007·Journal of Thrombosis and Haemostasis : JTH·J T BrandtK J Winters
Nov 6, 2007·The New England Journal of Medicine·Stephen D WiviottUNKNOWN TRITON-TIMI 38 Investigators
Nov 24, 2007·Cerebrovascular Diseases·Yasuo FukuuchiTakenori Yamaguchi
Jan 19, 2008·BMJ : British Medical Journal·George KrasopoulosMichael R Buchanan
Jan 29, 2008·Journal of Clinical Pharmacology·Francis M GengoVernice Bates
Jan 31, 2008·Clinical Pharmacology and Therapeutics·S P MyrandK D Wilner
Mar 8, 2008·Clinical Pharmacology and Therapeutics·K A KimJ-Y Park
Apr 5, 2008·Stroke; a Journal of Cerebral Circulation·Yukito ShinoharaUNKNOWN S-ACCESS Study Group
Sep 2, 2008·Circulation·Stephen D WiviottUNKNOWN TRITON-TIMI 38 Investigators
May 6, 2009·Circulation·Jessica L MegaMarc S Sabatine
Dec 22, 2011·Thrombosis and Haemostasis·Joseph A JakubowskiMaxime Moulard
Oct 31, 2013·Lancet·Colin P DerdeynUNKNOWN Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators
Apr 25, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Shigeru SaitoMasato Nakamura
May 3, 2014·Stroke; a Journal of Cerebral Circulation·Walter N KernanUNKNOWN American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and
Oct 25, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Takaaki IsshikiUNKNOWN PRASFIT-Elective Investigators
Mar 5, 2016·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Xingyang YiChun Wang
Jul 31, 2016·Drug Metabolism and Pharmacokinetics·Kazuo UmemuraKazunao Kondo
Apr 23, 2017·Journal of the Neurological Sciences·Aidonio FiolakiSotirios Giannopoulos
Citations
Jun 5, 2020·Journal of Atherosclerosis and Thrombosis·Takanari KitazonoUNKNOWN PRASTRO-I Study Group
Aug 19, 2020·International Journal of Environmental Research and Public Health·Salvatore Santo SignorelliAgostino Gaudio
Feb 11, 2021·Stroke; a Journal of Cerebral Circulation·Kazunori ToyodaUNKNOWN PRASTRO Trial Investigators*